BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16304992)

  • 1. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas.
    Conti A; Ageunnouz M; La Torre D; Cardali S; Angileri FF; Buemi C; Tomasello C; Iacopino DG; D'Avella D; Vita G; Tomasello F
    J Neurosurg; 2005 Nov; 103(5):873-81. PubMed ID: 16304992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
    Izban KF; Ergin M; Martinez RL; Alkan S
    Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human RPE expression of cell survival factors.
    Yang P; Wiser JL; Peairs JJ; Ebright JN; Zavodni ZJ; Bowes Rickman C; Jaffe GJ
    Invest Ophthalmol Vis Sci; 2005 May; 46(5):1755-64. PubMed ID: 15851579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
    Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
    Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AWP1 binds to tumor necrosis factor receptor-associated factor 2 (TRAF2) and is involved in TRAF2-mediated nuclear factor-kappaB signaling.
    Chang EJ; Ha J; Kang SS; Lee ZH; Kim HH
    Int J Biochem Cell Biol; 2011 Nov; 43(11):1612-20. PubMed ID: 21810480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling.
    Xie P; Hostager BS; Munroe ME; Moore CR; Bishop GA
    J Immunol; 2006 May; 176(9):5388-400. PubMed ID: 16622006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
    Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
    Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; Püschner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-kappaB activation.
    Henkler F; Baumann B; Fotin-Mleczek M; Weingärtner M; Schwenzer R; Peters N; Graness A; Wirth T; Scheurich P; Schmid JA; Wajant H
    J Biol Chem; 2003 Aug; 278(31):29216-30. PubMed ID: 12709429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling.
    Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T
    J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor necrosis factor (TNF) receptor-associated factor (TRAF)-interacting protein (TRIP) negatively regulates the TRAF2 ubiquitin-dependent pathway by suppressing the TRAF2-sphingosine 1-phosphate (S1P) interaction.
    Park ES; Choi S; Shin B; Yu J; Yu J; Hwang JM; Yun H; Chung YH; Choi JS; Choi Y; Rho J
    J Biol Chem; 2015 Apr; 290(15):9660-73. PubMed ID: 25716317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for TANK recognition by TRAF1 revealed by the crystal structure of TRAF1/TANK complex.
    Kim CM; Jeong JH; Son YJ; Choi JH; Kim S; Park HH
    FEBS Lett; 2017 Mar; 591(5):810-821. PubMed ID: 28155233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional characterization of TNF-α in grass carp head kidney leukocytes: induction and involvement in the regulation of NF-κB signaling.
    Zhang A; Chen D; Wei H; Du L; Zhao T; Wang X; Zhou H
    Fish Shellfish Immunol; 2012 Nov; 33(5):1123-32. PubMed ID: 22981915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the TNFR-receptor associated factor TRAF1 with I-kappa B kinase-2 and TRAF2 indicates a regulatory function for NF-kappa B signaling.
    Sughra K; Birbach A; de Martin R; Schmid JA
    PLoS One; 2010 Sep; 5(9):e12683. PubMed ID: 20856938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling.
    Guasparri I; Wu H; Cesarman E
    EMBO Rep; 2006 Jan; 7(1):114-9. PubMed ID: 16311516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anatomy of TRAF2. Distinct domains for nuclear factor-kappaB activation and association with tumor necrosis factor signaling proteins.
    Takeuchi M; Rothe M; Goeddel DV
    J Biol Chem; 1996 Aug; 271(33):19935-42. PubMed ID: 8702708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-kappaB activation.
    Fotin-Mleczek M; Henkler F; Hausser A; Glauner H; Samel D; Graness A; Scheurich P; Mauri D; Wajant H
    J Biol Chem; 2004 Jan; 279(1):677-85. PubMed ID: 14557256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
    Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation.
    Song HY; Rothe M; Goeddel DV
    Proc Natl Acad Sci U S A; 1996 Jun; 93(13):6721-5. PubMed ID: 8692885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.